124 related articles for article (PubMed ID: 15217193)
1. In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens.
Norcia LJ; Silvia AM; Santoro SL; Retsema J; Letavic MA; Bronk BS; Lundy KM; Yang B; Evans NA; Hayashi SF
J Antibiot (Tokyo); 2004 Apr; 57(4):280-8. PubMed ID: 15217193
[TBL] [Abstract][Full Text] [Related]
2. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.
Norcia LJ; Seibel SB; Kamicker BJ; Lemay MA; Lilley SC; Hecker SJ; Bergeron JM; Retsema JA; Hayashi SF
J Antibiot (Tokyo); 1998 Feb; 51(2):136-44. PubMed ID: 9544934
[TBL] [Abstract][Full Text] [Related]
3. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens.
Diarra MS; Malouin F; Jacques M
Int J Antimicrob Agents; 1999 Aug; 12(3):229-37. PubMed ID: 10461841
[TBL] [Abstract][Full Text] [Related]
4. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology.
Godinho KS; Keane SG; Nanjiani IA; Benchaoui HA; Sunderland SJ; Jones MA; Weatherley AJ; Gootz TD; Rowan TG
Vet Ther; 2005; 6(2):113-21. PubMed ID: 16094559
[TBL] [Abstract][Full Text] [Related]
5. Effect of tilmicosin on chemotactic, phagocytic, and bactericidal activities of bovine and porcine alveolar macrophages.
Brumbaugh GW; Herman JD; Clancy JS; Burden KI; Barry T; Simpson RB; López HS
Am J Vet Res; 2002 Jan; 63(1):36-41. PubMed ID: 16206777
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease.
Shin SJ; Kang SG; Nabin R; Kang ML; Yoo HS
Vet Microbiol; 2005 Mar; 106(1-2):73-7. PubMed ID: 15737475
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the RapID NH system for identification of Haemophilus somnus, Pasteurella multocida, Pasteurella haemolytica, and Actinobacillus pleuropneumoniae isolated from cattle and pigs with respiratory disease.
Salmon SA; Watts JL; Yancey RJ
J Clin Microbiol; 1993 May; 31(5):1362-3. PubMed ID: 8501242
[TBL] [Abstract][Full Text] [Related]
9. Short communication: Interaction of the isomers carvacrol and thymol with the antibiotics doxycycline and tilmicosin: In vitro effects against pathogenic bacteria commonly found in the respiratory tract of calves.
Kissels W; Wu X; Santos RR
J Dairy Sci; 2017 Feb; 100(2):970-974. PubMed ID: 28012625
[TBL] [Abstract][Full Text] [Related]
10. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
Dayao D; Gibson JS; Blackall PJ; Turni C
Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
[TBL] [Abstract][Full Text] [Related]
12. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
Shryock TR; Staples JM; DeRosa DC
J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of antimicrobial susceptibility of respiratory tract pathogens isolated from diseased cattle and pigs across Europe, 2009-2012: VetPath results.
El Garch F; de Jong A; Simjee S; Moyaert H; Klein U; Ludwig C; Marion H; Haag-Diergarten S; Richard-Mazet A; Thomas V; Siegwart E
Vet Microbiol; 2016 Oct; 194():11-22. PubMed ID: 27102206
[TBL] [Abstract][Full Text] [Related]
15. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
Portis E; Lindeman C; Johansen L; Stoltman G
J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of porcine respiratory pathogens to tilmicosin.
DeRosa DC; Veenhuizen MF; Bade DJ; Shryock TR
J Vet Diagn Invest; 2000 Nov; 12(6):541-6. PubMed ID: 11108454
[TBL] [Abstract][Full Text] [Related]
17. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
Stephens CP; Blackall PJ; Wade LK; Lowe LB
Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
[No Abstract] [Full Text] [Related]
18. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
[TBL] [Abstract][Full Text] [Related]
19. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
[No Abstract] [Full Text] [Related]
20. Studies on time-kill kinetics of different classes of antibiotics against veterinary pathogenic bacteria including Pasteurella, Actinobacillus and Escherichia coli.
Norcia LJ; Silvia AM; Hayashi SF
J Antibiot (Tokyo); 1999 Jan; 52(1):52-60. PubMed ID: 10092198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
